Ming-Szu Hung Selected Research

Ming-Szu Hung Research Topics

Disease

24	Lung Neoplasms (Lung Cancer) 10/2022 - 06/2009
24	Neoplasms (Cancer) 10/2022 - 03/2008
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 07/2006
4	Adenocarcinoma of Lung 03/2022 - 06/2016
4	Hemorrhage 12/2018 - 09/2007
3	Carcinogenesis 08/2021 - 12/2009
2	Pleural Effusion (Pleural Effusions) 07/2009 - 03/2008
2	Malignant Pleural Effusion 07/2009 - 07/2006
1	Dyspnea (Shortness of Breath) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Sepsis (Septicemia) 04/2023
1	Bacterial Infections (Bacterial Infection) 12/2022
1	Clostridium Infections 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Fatigue 01/2020
1	Hypesthesia (Numbness) 01/2020
1	Shock 05/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Diabetes Mellitus 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Out-of-Hospital Cardiac Arrest 11/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Genomic Instability 06/2014
1	Liver Neoplasms (Liver Cancer) 03/2011
1	Malignant Mesothelioma 02/2011
1	Mesothelioma 02/2011
1	Cardiac Arrhythmias (Arrythmia) 12/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2008
1	Infections 03/2008

Drug/Important Bio-Agent (IBA)

10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2006
7	Tyrosine Kinase InhibitorsIBA 03/2022 - 06/2016
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2010
6	Cullin Proteins (Cullins)IBA 01/2021 - 02/2011
5	Small Interfering RNA (siRNA)IBA 08/2021 - 07/2010
4	Gefitinib (Iressa)FDA Link 01/2022 - 07/2006
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 07/2009
3	Casein Kinase II (Casein Kinase 2)IBA 11/2013 - 05/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023 - 12/2016
2	Proton Pump InhibitorsIBA 01/2022 - 01/2019
2	AfatinibIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2019 - 01/2017
2	Gemcitabine FDA Link 01/2016 - 12/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 12/2015
2	hemateinIBA 11/2013 - 05/2009
2	LigandsIBA 07/2013 - 12/2009
1	Perilipin-3IBA 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	LipidsIBA 10/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2022
1	Growth Factor ReceptorsIBA 03/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	Annexin A1IBA 08/2021
1	osimertinibIBA 08/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	AntibodiesIBA 11/2020
1	Hormones (Hormone)IBA 01/2020
1	Dehydroepiandrosterone SulfateIBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 01/2020
1	Dehydroepiandrosterone (DHEA)IBA 01/2020
1	Circulating Tumor DNAIBA 06/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2019
1	AnnexinsIBA 05/2019
1	antineoplaston A10 (A 10)IBA 05/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	CreatinineIBA 12/2018
1	Urea (Carbamide)FDA LinkGeneric 12/2018
1	NitrogenIBA 12/2018
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 11/2018
1	EnzymesIBA 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	CrizotinibIBA 04/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	cadherin 5IBA 01/2016
1	Cre recombinaseIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 06/2014
1	pericentrinIBA 06/2014
1	Frizzled ReceptorsIBA 07/2013
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 07/2013
1	Local AnestheticsIBA 12/2009
1	Procaine (Novocaine)FDA LinkGeneric 12/2009
1	Procainamide (Procan)FDA LinkGeneric 12/2009
1	Complement System Proteins (Complement)IBA 07/2009
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2008

Therapy/Procedure

12	Therapeutics 03/2022 - 07/2006
6	Drug Therapy (Chemotherapy) 08/2021 - 06/2014
2	Investigational Therapies (Experimental Therapy) 07/2015 - 06/2014
1	Endurance Training 01/2024
1	Length of Stay 12/2022
1	Artificial Respiration (Mechanical Ventilation) 12/2022
1	Chemoradiotherapy 07/2019
1	Radiotherapy 07/2019
1	Resuscitation 01/2019
1	Erythrocyte Transfusion 01/2018